IONIS PHARMACEUTICALS INC — Director's Dealing 2019

Jun 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2019-06-10

Reporting Person: HERMAN JOAN E (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-10	Director Stock Option (right to buy)	$63.90	A	32000	Acquired	2029-06-09	Common Stock (32000)	Direct

Footnotes

F1: Grant of June 10, 2019 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on June 10, 2020. The option shall be fully vested and exercisable on June 10, 2023. The option is exercisable to 0 shares on June 10, 2019.